Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124128052 | 12412805 | 2 | F | 201512 | 20160830 | 20160527 | 20160906 | PER | US-PFIZER INC-2016256797 | PFIZER | 59.00 | YR | M | Y | 111.13000 | KG | 20160906 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124128052 | 12412805 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 100 MG, UNK | 21992 | 100 | MG | PROLONGED-RELEASE TABLET | ||||||||
| 124128052 | 12412805 | 2 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 21992 | PROLONGED-RELEASE TABLET | |||||||||||
| 124128052 | 12412805 | 3 | SS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | 150 MG, 2X/DAY | Y | W27086 | 0 | 150 | MG | BID | ||||||
| 124128052 | 12412805 | 4 | SS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Y | 0 | |||||||||||
| 124128052 | 12412805 | 5 | C | KLONOPIN | CLONAZEPAM | 1 | 1 MG, 2X/DAY | 0 | 1 | MG | TABLET | BID | |||||||
| 124128052 | 12412805 | 6 | C | BUPROPION HYDROCHLORIDE. | BUPROPION HYDROCHLORIDE | 1 | 200 MG, 2X/DAY | 0 | 200 | MG | BID | ||||||||
| 124128052 | 12412805 | 7 | C | XELJANZ | TOFACITINIB CITRATE | 1 | 5 MG, 2X/DAY | N58405 | 0 | 5 | MG | BID | |||||||
| 124128052 | 12412805 | 8 | C | DICLOFENAC W/MISOPROSTOL | DICLOFENAC SODIUMMISOPROSTOL | 1 | UNK | 0 | |||||||||||
| 124128052 | 12412805 | 9 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | UNK UNK, 1X/DAY(2 PUFFS ) | 0 | QD | ||||||||||
| 124128052 | 12412805 | 10 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | UNK, 2X/DAY(1000) | 1097-000215 | 0 | BID | |||||||||
| 124128052 | 12412805 | 11 | C | METHOTREXATE. | METHOTREXATE | 1 | 0.5 ML, WEEKLY | 0 | .5 | ML | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124128052 | 12412805 | 1 | Major depression |
| 124128052 | 12412805 | 2 | Anxiety |
| 124128052 | 12412805 | 3 | Major depression |
| 124128052 | 12412805 | 4 | Anxiety |
| 124128052 | 12412805 | 5 | Anxiety |
| 124128052 | 12412805 | 6 | Major depression |
| 124128052 | 12412805 | 7 | Rheumatoid arthritis |
| 124128052 | 12412805 | 10 | Diabetes mellitus |
| 124128052 | 12412805 | 11 | Rheumatoid arthritis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124128052 | 12412805 | Disturbance in attention | |
| 124128052 | 12412805 | Drug ineffective | |
| 124128052 | 12412805 | Erectile dysfunction | |
| 124128052 | 12412805 | Fatigue | |
| 124128052 | 12412805 | Glucose tolerance impaired | |
| 124128052 | 12412805 | Libido decreased | |
| 124128052 | 12412805 | Sluggishness | |
| 124128052 | 12412805 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124128052 | 12412805 | 1 | 2006 | 201206 | 0 | |
| 124128052 | 12412805 | 3 | 2016 | 0 | ||
| 124128052 | 12412805 | 5 | 20090601 | 0 | ||
| 124128052 | 12412805 | 6 | 20090601 | 0 | ||
| 124128052 | 12412805 | 7 | 20130301 | 0 | ||
| 124128052 | 12412805 | 8 | 20060401 | 0 | ||
| 124128052 | 12412805 | 10 | 20160401 | 0 | ||
| 124128052 | 12412805 | 11 | 20060401 | 0 |